Maine v. Equity Corporation International, No. CV-98-312 (Kennebec Super. Ct. 1998)
Complaint under state merger law resolved by Consent Decree requiring funeral home divestiture.
In re Maine Pride Salmon, No. 93-10580 (Bankr. D. Maine 1993)
Challenge to proposed merger of salmon aquaculture compnay in bankruptcy.
Maine v. Cardovascular & Thoracic Associates, PA; 1992 WL 503594 (Me. Super. Sept. 2, 1992)
Maine challenged merger of cardiac surgere practices.
Maine v. Mid Coast Anesthesia, 1992 WL 38176 (Me.Super.), 1991-2 Trade Cases P 69,683 (Jan. 10. 1992)
State challenged merger of anesthesiology groups.
Maine v. Scott Paper Co., 1987-2 Trade Cas. 67,786 (Somerset Super. Ct., Me., Nov. 25, 1987)
State’s complaint charged paper manufacturer with tying purchase of pulpwood from contractors or brokers to the purchase of sawlogs by the contractor or broker.
Maine v. Trainor, No. CV-87-260 (Kennebec Super. Ct. July 1987)
State’s complaint alleged conspiracy to monopolize ownership and control of commercial solid waste landfills in the state and violation so fsecurities laws by an entierprise engaged in development, ownership and control of commercial solid waste landfills.
Maine v. McCain Foods, 1987-2 Trade Case. (CCH) ¶¶ 67, 798 (Me. Super. Ct. 1987)
Complaint charged potato processor with tying, specifically that processor conditioned award of sought-after seasonal potato contracts on growers’ purchases of fertilizer or agricultural equipment or machinery manufactured by processor’s affiliate.
Maine v. Business Equipment Unlimited No. CV-87-103 (Kennebec Superior Court)
Complaint charging price-fixing and market allocation in the sale of toner, resolved by Consent Decree ordering injunctive relief and $35,000 civil penalties against four defendants.
Maine v. Bar Harbor Airways, Inc. No. 86-179 (Kennebec Superior Ct., June 9, 1987)
Merger of two small airlines in the same relevant geographical area.
Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)
States sued manufacturer of antitdepressant Paxil, alleging patent misuse and sham litigation designed to prevent generic entry. Parties settled for $14 million.
